Zhichao Lang

Zhejiang Key Laboratory Of Intelligent Cancer Biomarker Discovery And Translation
Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

ATF3-mediated transactivation of CXCL14 in HSCs during liver fibrosis.

ATF3-mediated transactivation of CXCL14 in HSCs during liver fibrosis.

Journal: Clinical and translational medicine

Published: July 27, 2024

Schisandrin B Promotes Hepatic Stellate Cell Ferroptosis via Wnt Pathway-Mediated Ly6Clo Macrophages.

Schisandrin B Promotes Hepatic Stellate Cell Ferroptosis via Wnt Pathway-Mediated Ly6Clo Macrophages.

Journal: Journal of agricultural and food chemistry

Published: November 03, 2023

Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression.

Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 07, 2023

Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis.

Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis.

Journal: Journal of pharmaceutical analysis

Published: August 29, 2023

Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patients.

Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patients.

Journal: Journal of medical virology

Published: June 11, 2023

Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11.

Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 15, 2023

Circular RNA cVIM promotes hepatic stellate cell activation in liver fibrosis via miR-122-5p/miR-9-5p-mediated TGF-β signaling cascade.

Circular RNA cVIM promotes hepatic stellate cell activation in liver fibrosis via miR-122-5p/miR-9-5p-mediated TGF-β signaling cascade.

Journal: Communications biology

Published: April 21, 2023

LncRNA-SNHG5 mediates activation of hepatic stellate cells by regulating NF2 and Hippo pathway.

LncRNA-SNHG5 mediates activation of hepatic stellate cells by regulating NF2 and Hippo pathway.

Journal: Communications biology

Published: April 19, 2023

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells.

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells.

Journal: Cell death discovery

Published: April 13, 2023

GAS5-inhibited hepatocyte pyroptosis contributes to hepatic stellate cell inactivation via microRNA-684 and AHR.

GAS5-inhibited hepatocyte pyroptosis contributes to hepatic stellate cell inactivation via microRNA-684 and AHR.

Journal: iScience

Published: April 01, 2023

Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.

Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.

Journal: BMC cancer

Published: February 19, 2023

A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia.

A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia.

Journal: Frontiers in oncology

Published: August 19, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026